Geographical variation in opioid prescribing and opioid-related mortality in Ontario

No abstract available.

Information

Citation

Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, Mamdani M. Healthc Q. 2011;14(1):22-4.

Contributing ICES Scientists

Research Programs

Chronic Disease & Pharmacotherapy

Associated Topics

Pharmacoepidemiology and drug safety

Associated Sites

Discover More

Journal Article

Duration of systemic therapy in patients with metastatic EGFR-mutated non-small cell lung cancer and brain metastases

Yan M, Tjong M, Coburn N, Nguyen L, Sahgal A, Louie AV, Parmar A. Transl Lung Cancer Res. 2026; 15(5):120. Epub 2026 May 26.

Journal Article

Risk of serious adverse events and death with low-dose methotrexate versus hydroxychloroquine in adults receiving dialysis

Muanda FT, Blake PG, Weir MA, Ahmadi F, Omrani MA, Abdullah SS, McArthur E, Sontrop JM, Urquhart BL, Garg AX. Semin Dial. 2026; May 12 [Epub ahead of print].

Journal Article

Effectiveness and safety of SGLT2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study

Wu CY, Shah BR, Ezekowitz JA, Sharma A, Wang T, Wu CF, Liu PP, Edwards JD, Swardfager W. Eur Heart J Cardiovasc Pharmacother. 2026; May 7 [Epub ahead of print].